Explore the scientific and regulatory hurdles of developing complex generic drugs. Learn why proving bioequivalence for inhalers, gels, and injectables is far harder than for traditional pills.
Learn how pediatric exclusivity allows the FDA to extend drug patent protection by six months. Discover the mechanics, strategic value, and impact on generics.
Discover how first-mover advantage shapes success for generic drug makers. Learn why timing matters, how the Hatch-Waxman Act works, and what strategies top companies use to stay ahead.
Learn how batch release testing prevents pharmaceutical recalls and ensures drug safety. A guide to GMP compliance, QP certification, and the shift toward AI-driven release.